title: Rotavirus replication: plus-sense templates for double-stranded RNA synthesis are made in viroplasms.
abstract: Rotavirus plus-strand RNAs not only direct protein synthesis but also serve as templates for the synthesis of the segmented double-stranded RNA (dsRNA) genome. In this study, we identified short-interfering RNAs (siRNAs) for viral genes 5, 8, and 9 that suppressed the expression of NSP1, a nonessential protein; NSP2, a component of viral replication factories (viroplasms); and VP7, an outer capsid protein, respectively. The loss of NSP2 expression inhibited viroplasm formation, genome replication, virion assembly, and synthesis of the other viral proteins. In contrast, the loss of VP7 expression had no effect on genome replication; instead, it inhibited only outer-capsid morphogenesis. Similarly, neither genome replication nor any other event of the viral life cycle was affected by the loss of NSP1. The data indicate that plus-strand RNAs templating dsRNA synthesis within viroplasms are not susceptible to siRNA-induced RNase degradation. In contrast, plus-strand RNAs templating protein synthesis in the cytosol are susceptible to degradation and thus are not the likely source of plus-strand RNAs for dsRNA synthesis in viroplasms. Indeed, immunofluorescence analysis of bromouridine (BrU)-labeled RNA made in infected cells provided evidence that plus-strand RNAs are synthesized within viroplasms. Furthermore, transfection of BrU-labeled viral plus-strand RNA into infected cells suggested that plus-strand RNAs introduced into the cytosol do not localize to viroplasms. From these results, we propose that plus-strand RNAs synthesized within viroplasms are the primary source of templates for genome replication and that trafficking pathways do not exist within the cytosol that transport plus-strand RNAs to viroplasms. The lack of such pathways confounds the development of reverse genetics systems for rotavirus.
authors.affiliation: Laboratory of Infectious Diseases, Nationa Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892-8026, USA.
authors.forename: Lynn S
authors.initials: LS
authors.lastname: Silvestri
authors.forename: Zenobia F
authors.initials: ZF
authors.lastname: Taraporewala
authors.forename: John T
authors.initials: JT
authors.lastname: Patton
mesh_terms: D000818:Animals; D000956:Antigens, Viral; D036022:Capsid Proteins / Q000235:genetics; D002460:Cell Line; D002479:Inclusion Bodies / Q000821:virology*; D034622:RNA Interference; D012330:RNA, Double-Stranded / Q000096:biosynthesis* / Q000235:genetics; D034741:RNA, Small Interfering / Q000235:genetics*; D012367:RNA, Viral / Q000096:biosynthesis / Q000235:genetics; D012401:Rotavirus / Q000235:genetics* / Q000378:metabolism; D013698:Templates, Genetic; D014162:Transfection; D017361:Viral Nonstructural Proteins / Q000235:genetics; D019065:Virus Assembly; D014779:Virus Replication
chemical_list: D000956:Antigens, Viral; D036022:Capsid Proteins; D012330:RNA, Double-Stranded; D034741:RNA, Small Interfering; D012367:RNA, Viral; C050779:VP7 protein, Rotavirus; D017361:Viral Nonstructural Proteins